Novel selenoesters as a potential tool in triple-negative breast cancer treatment

HIGHLIGHTS

• who: Dominika Radomska and collaborators from the Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego, Bialystok, Poland have published the Article: Novel Selenoesters as a Potential Tool in Triple-Negative Breast Cancer Treatment, in the Journal: Cancers 2022, 4304 of /2022/
• what: The aim of the study was an in-depth evaluation of the anticancer activity of novel selenoesters (EDA-71, E-NS-4) in MCF-7 and MDA-MB-231 human breast cancer cells. In the present study, cells that obtained 80% of confluence were used. The authors demonstrated that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.